Intrinsic Value of S&P & Nasdaq Contact Us

Immatics N.V. IMTX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • DE • USD

SharesGrow Score
57/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$21.00
+91.8%

Stock Statistics — IMTX

Immatics N.V. (IMTX) has a market capitalization of $1.47B and trades at $10.95. The 52-week range is 3.3-12.41.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -7.1, Earnings Per Share (EPS) of $-1.54, annual revenue of $48.27M.

The stock has a beta of 1.34, operates in the Healthcare sector.

Trading Data
Current Price$10.95
52-Week Range3.3-12.41
Volume241.26K
Avg Volume (30D)453.71K
Market Cap$1.47B
Beta (1Y)1.34
Company
IPO Date2018-12-12
Employees554
CEOHarpreet Singh
CountryDE
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINNL0015285941
CUSIPN44445109
Income (Latest Year)
Revenue$48.27M
Gross Profit$48.27M
EBITDA$-167.47M
Operating Income$-179.38M
Net Income$-188.69M
EPS$-1.54
EPS Diluted$-1.54
Shares Outstanding$122.35M
Balance Sheet (Latest Year)
Total Assets$562.1M
Current Assets$503.79M
Cash & ST Investments$469.14M
Total Liabilities$78.2M
Total Debt$15.63M
Net Debt$-330.14M
Total Equity$483.89M
Debt / Equity0.03
Valuation Ratios
P/E Ratio-7.1
P/S Ratio30.41
P/B Ratio3.03
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message